| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.07 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.099 | 0.08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.08 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.29 | 0.08 |